Inventor · disambiguated record
D. Christopher Schelling
Also filed as: SCHELLING D CHRISTOPHER
3 granted patents·7 pending applications·0 citations·filing 2016–2022
54Inventor score
Top patents by PatentIndex Score
10 records- 0175US2023133629A1Palatable compositions including sodium phenylbutyrate and uses thereofACER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0271US11202767B2Methods of treating urea cycle disorders and maple syrup urine diseaseACER THERAPEUTICS INC·Filed 2021·Granted Dec 21, 2021·0 cites·27 claims
- 0371US11154521B2Palatable compositions including sodium phenylbutyrate and uses thereofACER THERAPEUTICS INC·Filed 2021·Granted Oct 26, 2021·0 cites·27 claims
- 0467US11433041B2Palatable compositions including sodium phenylbutyrate and uses thereofACER THERAPEUTICS[ ] INC·Filed 2020·Granted Sep 6, 2022·0 cites·24 claims
- 0556US2024342104A1Dosage form for improving palatability of drug substanceACER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0654US2017266115A1Palatable compositions including sodium phenylbutyrate and uses thereofACER THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 0751US2022356471A1Correction of exon skipping in monocyte-derived cells for improved immune responseSCHELLING D CHRISTOPHER·Filed 2022·Application pending·0 cites
- 0847US2023338355A1Nk antagonists for contraceptionACER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0946US2023248657A1Methods of administering taste masked phenylbutyrate and compositions thereforACER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1043US2023277518A1Nk receptor antagonists for cancer patientsACER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when D. Christopher Schelling files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →